Get started
MarketMoversReport

Antares Pharma Announces FDA Approval Of TLANDO

Long
MarketMoversReport  
NASDAQ:ATRS   None
Beyond Technical Analysis
0
0
beyondta
ATRS: Antares Pharma, Inc.
2022-03-29 07:00:00
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.